PK MED revamps governance as ARTHRELIS heads toward Phase 2

The French biotech named François Romaneix board chair and added Philippe Leboulch, Alain Fischer, Isabelle Buckle and Tom Tice as it advances ARTHRELIS and ENGRAFTIS.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.